Maynard Um
-
-
-
-
-
-
-
West Pharmaceutical (WST) PT Raised to $390 at Evercore ISI
-
-
-
-
-
-
-
Nephron Upgrades West Pharmaceutical (WST) to Buy
-
-
-
-
-
-
-
West Pharmaceutical (WST) PT Raised to $370 at BofA Securities
-
-
-
-
-
-
-
West Pharma (WST) call put ratio 2.8 calls to 1 put with a focus on December calls as share price up 20%
-
-
-
-
-
-
-
WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
-
-
-
-
-
-
WST FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securit
-
-
-
-
-
-
-
WST FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important July 7 Deadline in Securities Class Action - WST
-
396,356 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

